TScan Therapeutics, Inc.·4

Feb 2, 4:21 PM ET

Amello Jason 4

4 · TScan Therapeutics, Inc. · Filed Feb 2, 2024

Insider Transaction Report

Form 4
Period: 2024-02-01
Amello Jason
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-01+750,000750,000 total
    Exercise: $5.15Exp: 2034-01-31Voting Common Stock (750,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 29, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4